Pharmaceuticals, Biotechnology and Life Sciences
Index Ventures, an early investor in technology hits like Skype and Dropbox, is spinning off its biotech portfolio into a new $1 billion (695 million pounds) business, with backing from drug giants GlaxoSmithKline and Johnson & Johnson .
Premaitha Health, the developer of IONA test, has partnered with Leeds Teaching Hospitals NHS Trust to provide a private NIPT…
Cancer drug maker Roche followed Swiss rival Novartis in disappointing shareholders with a muted forecast for the year, sending its shares lower on Thursday.
By Pamela Barbaglia LONDON (Reuters) – European buyout firm Charterhouse [CHCAP.UL] is preparing for the sale of its Italian generic…
Hikma Pharmaceuticals has prepared a combined Prospectus that contains the formal notice of meeting for the general meeting, to be…
Five charged in U.S. with stealing secrects from GlaxoSmithKline
Glenmark Pharmaceuticals entering $130M market with Actavis’ Potassium Cholire capsules and generics of Warner Chilcott’s Loestrin tablets
Indian pharmaceutical company Natco Pharma Limited has signed a nonexclusive, royalty free licensing agreement with the Medicines Patent Pool and…
Former drug executive Martin Shkreli plans to hire new legal counsel to represent him against U.S. charges that he defrauded investors at his former hedge fund and a pharmaceutical company he headed, Shkreli’s current lawyers said.
Biofrontera, the biopharmaceutical company focusing on sun-induced skin cancer, has decided to cancel the admission of its ordinary shares to trading…